Month: August 2019
Novartis scores another point in multiple sclerosis therapy, stock rises
Swiss pharmaceutical giant Novartis International AG (NYSE: NVS) on Friday said its ofatumumab met the primary and secondary endpoints of…
Marvell Technology stock dwindles on weak outlook despite q2 earnings beat
Marvell Technology Group (NASDAQ: MRVL) stock was down more than 5% in the after-market trading session as the Q3 outlook…